Northern Trust’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.17M Sell
459,124
-30,250
-6% -$143K ﹤0.01% 2938
2025
Q1
$2.25M Sell
489,374
-18,068
-4% -$82.9K ﹤0.01% 2858
2024
Q4
$2.43M Buy
507,442
+6,283
+1% +$30.1K ﹤0.01% 2912
2024
Q3
$2.35M Buy
501,159
+14,248
+3% +$66.8K ﹤0.01% 2900
2024
Q2
$2.75M Sell
486,911
-7,829
-2% -$44.2K ﹤0.01% 2730
2024
Q1
$2.03M Sell
494,740
-13,845
-3% -$56.9K ﹤0.01% 2951
2023
Q4
$2.15M Sell
508,585
-52,752
-9% -$223K ﹤0.01% 2970
2023
Q3
$2.42M Sell
561,337
-34,163
-6% -$148K ﹤0.01% 2830
2023
Q2
$3.92M Sell
595,500
-783
-0.1% -$5.16K ﹤0.01% 2637
2023
Q1
$4.05M Buy
596,283
+10,260
+2% +$69.7K ﹤0.01% 2586
2022
Q4
$4.33M Sell
586,023
-8,567
-1% -$63.3K ﹤0.01% 2570
2022
Q3
$5.88M Sell
594,590
-2,551
-0.4% -$25.2K ﹤0.01% 2371
2022
Q2
$6.51M Buy
597,141
+232
+0% +$2.53K ﹤0.01% 2335
2022
Q1
$6.75M Sell
596,909
-195,342
-25% -$2.21M ﹤0.01% 2396
2021
Q4
$12.4M Sell
792,251
-7,221
-0.9% -$113K ﹤0.01% 2083
2021
Q3
$13.7M Sell
799,472
-20,681
-3% -$354K ﹤0.01% 2055
2021
Q2
$17.6M Buy
820,153
+194,483
+31% +$4.18M ﹤0.01% 1974
2021
Q1
$9.4M Sell
625,670
-24,562
-4% -$369K ﹤0.01% 2336
2020
Q4
$8.54M Sell
650,232
-33,695
-5% -$443K ﹤0.01% 2352
2020
Q3
$6.61M Sell
683,927
-27,624
-4% -$267K ﹤0.01% 2366
2020
Q2
$8.14M Sell
711,551
-8,525
-1% -$97.5K ﹤0.01% 2226
2020
Q1
$7.46M Buy
720,076
+4,126
+0.6% +$42.7K ﹤0.01% 2068
2019
Q4
$11.7M Sell
715,950
-16,983
-2% -$279K ﹤0.01% 2078
2019
Q3
$9.73M Buy
732,933
+26,267
+4% +$349K ﹤0.01% 2161
2019
Q2
$9.96M Buy
706,666
+6,938
+1% +$97.8K ﹤0.01% 2161
2019
Q1
$12.9M Buy
699,728
+4,290
+0.6% +$78.9K ﹤0.01% 1984
2018
Q4
$18.2M Sell
695,438
-6,583
-0.9% -$172K 0.01% 1664
2018
Q3
$16.1M Buy
702,021
+25,721
+4% +$590K ﹤0.01% 1945
2018
Q2
$12.9M Buy
676,300
+91,539
+16% +$1.74M ﹤0.01% 2097
2018
Q1
$9.85M Buy
584,761
+6,730
+1% +$113K ﹤0.01% 2179
2017
Q4
$8.79M Sell
578,031
-13,755
-2% -$209K ﹤0.01% 2274
2017
Q3
$10.6M Sell
591,786
-6,142
-1% -$110K ﹤0.01% 2166
2017
Q2
$9.75M Buy
597,928
+84,834
+17% +$1.38M ﹤0.01% 2197
2017
Q1
$7.18M Buy
513,094
+28,542
+6% +$400K ﹤0.01% 2339
2016
Q4
$7.73M Buy
484,552
+2,533
+0.5% +$40.4K ﹤0.01% 2272
2016
Q3
$8.02M Sell
482,019
-578
-0.1% -$9.62K ﹤0.01% 2210
2016
Q2
$5.4M Sell
482,597
-46,656
-9% -$522K ﹤0.01% 2401
2016
Q1
$4.43M Buy
529,253
+23,202
+5% +$194K ﹤0.01% 2481
2015
Q4
$4.71M Buy
506,051
+28,620
+6% +$266K ﹤0.01% 2490
2015
Q3
$5.39M Buy
477,431
+63,275
+15% +$714K ﹤0.01% 2396
2015
Q2
$5.26M Sell
414,156
-48,446
-10% -$615K ﹤0.01% 2481
2015
Q1
$4.3M Buy
462,602
+14,804
+3% +$138K ﹤0.01% 2600
2014
Q4
$6.41M Buy
447,798
+43,874
+11% +$628K ﹤0.01% 2339
2014
Q3
$4.19M Buy
403,924
+3,060
+0.8% +$31.8K ﹤0.01% 2622
2014
Q2
$6.49M Sell
400,864
-47,223
-11% -$764K ﹤0.01% 2347
2014
Q1
$7.28M Sell
448,087
-44,319
-9% -$720K ﹤0.01% 2322
2013
Q4
$6.11M Buy
492,406
+45,012
+10% +$559K ﹤0.01% 2417
2013
Q3
$4.9M Buy
447,394
+48,214
+12% +$528K ﹤0.01% 2520
2013
Q2
$3.23M Buy
+399,180
New +$3.23M ﹤0.01% 2687